Comments
Melbourne-based Akaal Pharma has entered into joint venture with Bengaluru-based Bal Pharma.
As a part of this JV, the venture called AB VET, will be funded by Bal Pharma to develop Akaal Pharma's Intellectual Property (IP) in the veterinary field, the company said in a statement.
The first veterinary indication will be against Atopic Dermatitis in dogs, wherein Akaal's ABV-119 is used to treat them.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.